Group structure
6 companies in 3 countries
United States2
United Kingdom1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading your pageโฆ
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 33
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| SCALPSYNC ANTI-DANDRUFF1 % / w/w ยท Shampoo | Pyrithione zinc | Canada | Marketed | 2014 |
| STERI-STAT4% ยท Solution | Chlorhexidine | United States | Not marketed | 1986 |
| CROSS FIRE1.085 % + 0.407 % + 0.407 % + 0.814 % ยท Liquid | Benzalkonium, Didecyl dimethyl ammonium, Dioctyl dimethyl ammonium, Octyl decyl dimethyl ammonium | Canada | Not marketed | 2013 |
| CROSSFIRE 2568.68 % / w/w + 3.255 % / w/w + 3.255 % / w/w + 6.51 % / w/w ยท Solution | Benzalkonium, Didecyl dimethyl ammonium, Dioctyl dimethyl ammonium, Octyl decyl dimethyl ammonium | Canada | Marketed | 2023 |
| NOVUS50 % / w/w ยท Solution | Hydrogen peroxide | Canada | Marketed | 2021 |
| VITA PRO SOLUBLE7.14 g / 400 g + 3200 mg / 400 g + 5760 mg / 400 g + 150 mg / 400 g + 7.14 g / 400 g + 500 mg / 400 g + 6720 mg / 400 g + 14.28 g / 400 g + 35.71 g / 400 g + 277.71 g / 400 g + 7.14 g / 400 g + 1280000 unit / 400 g + 2560 mcg / 400 g + 1280 mg / 400 g + 1000000 unit / 400 g + 1500 unit / 400 g ยท Powder For Solution | Calcium acetate, D-pantothenic acid, Choline, Folic acid, Magnesium chloride anhydrous, Menadione, Nicotinamide, Potassium chloride, Sodium acetate, Sodium chloride, Diacetate, Vitamin a, Vitamin b12, Vitamin b2, Vitamin d, Vitamin e | Canada | Marketed | 2012 |
| ACTIVE CONTROL1 % ยท Shampoo | Pyrithione zinc | Canada | Cancelled | 2006 |
| ACTROL DANDRUFF SHAMPOO1 % ยท Shampoo | Pyrithione zinc | Canada | Cancelled | 2003 |
| ACTROL DANDRUFF SHAMPOO - 1.2%1.2 % ยท Shampoo | Pyrithione zinc | Canada | Cancelled | 1995 |
| ACTROL DANDRUFF SHAMPOO 1.2%1.2 % ยท Shampoo | Pyrithione zinc | Canada | Cancelled | 1988 |
| ATAZANAVIR SULFATE AND RITONAVIR300mg/100mg ยท Tablet | Atazanavir, Ritonavir | United States | tentative | 2011 |
| BIOLAGE SCALPTHรRAPIE ANTIDANDRUFF CONDITIONER1 % ยท Cream | Pyrithione zinc | Canada | Cancelled | 2009 |
| BIOLAGE SCALPTHERAPIE ANTIDANDRUFF SHAMPOO1 % ยท Shampoo | Pyrithione zinc | Canada | Cancelled | 2009 |
| BIOLAGE SCALPTHERAPIE ANTIDANDRUFF TREATMENT0.1 % ยท Gel | Pyrithione zinc | Canada | Cancelled | 2009 |
| BIOLAGESUN A D.I.T.S. S.C. S.B. WP SPF 307 % / % + 5 % / % + 6 % / % ยท Lotion | Octinoxate, Octisalate, Oxybenzone | Canada | Cancelled | 1995 |
| BIOLAGESUN F.T.S. SENS. SK. SUN BL. WP.SPF307 % / % + 5 % / % + 6 % / % ยท Cream | Octinoxate, Octisalate, Oxybenzone | Canada | Cancelled | 1995 |
| BIOLAGESUN S.S. SKIN-CARING S.S. WP. SPF 155 % / % + 5 % / % + 6 % / % ยท Lotion | Octinoxate, Octisalate, Oxybenzone | Canada | Cancelled | 1995 |
| BIOLAGESUN T.T.T. SKIN-CARING S.S. WP SPF 84 % / % + 4 % / % + 3 % / % ยท Lotion | Octinoxate, Octisalate, Oxybenzone | Canada | Cancelled | 1995 |
| CALF PRO0.012 g / 76 g + 41.734 g / 76 g + 6.756 g / 76 g + 1.94 g / 76 g + 0.349 g / 76 g + 13.125 g / 76 g + 3.507 g / 76 g + 0.6 g / 76 g ยท Powder For Solution | D-pantothenic acid, Dextrose, Glycine, Potassium chloride, Dibasic, Sodium acetate, Sodium chloride, Monobasic | Canada | Cancelled | |
| EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE200mg; 300mg ยท Tablet | Emtricitabine, Tenofovir disoproxil | United States | tentative | 2009 |
| FLUIDITY TREATMENT MAKEUP SPF 64 % / % ยท Liquid | Titanium dioxide | Canada | Cancelled | 1996 |
| LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE150mg; 200mg; 300mg ยท Tablet | Lamivudine, Nevirapine, Zidovudine | United States | tentative | 2008 |
| LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS30mg; 50mg; 60mg ยท Tablet, for suspension | Lamivudine, Nevirapine, Zidovudine | United States | tentative | 2010 |
| LAMIVUDINE; STAVUDINE150mg; 30mg | 150mg; 40mg ยท Tablet | Lamivudine, Stavudine | United States | tentative | 2007 |
| LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE300mg; 300mg; 200mg ยท Tablet | Lamivudine, Tenofovir disoproxil, Nevirapine | United States | tentative | 2011 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 26 | 5 | 21 | CompaniesAll medicines |
| United States | 7 | 1 | 6 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.